Lineage Cell Therapeutics Inc
LCTX
$0.99+0.26%
End of day · as of Oct 17, 2026, 11:00 AM ET
Mkt cap
$213.56M
EV/Sales
11.9
P/E ratio
N/A
FY2025 Revenue
$14.56M
EPS (TTM)
$-0.19
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-436.47%
Beta
1.52
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported LCTX revenue for 2025-12-31 was $14.6M. Net income was -$63.5M. Revenue was up 53.2% from 2024-12-31 to 2025-12-31. LCTX currently screens at market cap $213.6M.
Use this LCTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LCTX income, balance, and cash tables.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company in the Healthcare sector.
Latest cached Lineage Cell Therapeutics Inc (LCTX) revenue for Dec 31, 2025 was $14.6M. Net income was -$63.5M. Statements: https://lician.com/financials/lctx
Lineage Cell Therapeutics Inc (LCTX) market capitalization is $213.6M on the latest cached snapshot.
Lineage Cell Therapeutics Inc (LCTX) cached previous close $0.99; day range $0.98 – $0.99; volume 1,215,272. Session quote: https://lician.com/quote/lctx
Lineage Cell Therapeutics Inc (LCTX) latest cached earnings event is "LCTX earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings